Holen Sie sich die Stockscreener-App
25.68
3.42%
0.8631
Acadia Pharmaceuticals Inc Aktie (ACAD) Neueste Nachrichten
Acadia Pharmaceuticals stock hits 52-week high at 25.24 USD By Investing.com - Investing.com Australia
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 11, 2025 - BioSpace
ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
JMP Securities Boosts ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $38.00 - MarketBeat
ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Raised to $17.00 at The Goldman Sachs Group - MarketBeat
Buy Rating on ACADIA Pharmaceuticals Driven by Daybue’s Sales Growth and Market Expansion - TipRanks
Results: ACADIA Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth - MSN
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2025 Earnings Call Transcript - Insider Monkey
Earnings Beat: ACADIA Pharmaceuticals Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - 富途牛牛
ACADIA Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Acadia Pharmaceuticals (ACAD) Shares Surge 3.07% to New Peak on Q2 Earnings, Patent Wins - AInvest
Why ACADIA Pharmaceuticals Inc. (ACAD) Skyrocketed on Friday - MSN
ACADIA Pharmaceuticals Reports Strong Q2 2025 Earnings - TipRanks
Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates - MSN
Acadia Pharmaceuticals stock price target raised to $24 from $18 at Stifel - Investing.com Canada
Mizuho Maintains Neutral Rating, Raises Price Target for ACADIA Pharmaceuticals to $24 - AInvest
A Quick Look at Today's Ratings for ACADIA Pharmaceuticals(ACAD.US), With a Forecast Between $17 to $38 - 富途牛牛
Mizuho raises Acadia Pharmaceuticals stock price target on solid earnings By Investing.com - Investing.com Canada
Mizuho raises Acadia Pharmaceuticals stock price target on solid earnings - Investing.com
Acadia Pharmaceuticals price target raised to $38 from $37 at Citizens JMP - TipRanks
Acadia Pharmaceuticals price target raised to $27 from $23 at BofA - TipRanks
Acadia Pharmaceuticals Beats Q2 Earnings ForecastsNews and Statistics - IndexBox
Acadia Pharmaceuticals stock price target raised to $38 from $37 at Citizens JMP - Investing.com Australia
Acadia Pharmaceuticals shares rise 2.10% premarket after FDA approves expanded indication for AJOVY. - AInvest
Acadia Pharmaceuticals Raises Guidance As Sales Climb In Q2 - Finimize
Earnings call transcript: ACADIA Pharmaceuticals Q2 2025 beats forecasts By Investing.com - Investing.com Canada
Instagram Rolls Out New Features for Personalized Content Discovery and Sharing - AInvest
ACADIA Pharmaceuticals Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:ACAD) - Seeking Alpha
Earnings call transcript: ACADIA Pharmaceuticals Q2 2025 beats forecasts - Investing.com
Transcript : ACADIA Pharmaceuticals Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Acadia Pharmaceuticals Q2 Earnings Fall, Revenue Rises - MarketScreener
Acadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating Overview - BioSpace
ACADIA Pharmaceuticals Q2 2025 Earnings Call Transcript - MarketBeat
Acadia Pharmaceuticals Reports Strong Q2 2025 Growth - TipRanks
Neuren Pharma shares soar on Q2 royalties growth - Capital Brief
Revamping Acadia - BioCentury
Acadia Pharmaceuticals Q2 2025 slides: revenue up 9%, raises full-year guidance - Investing.com Australia
Acadia: Q2 Earnings Snapshot - The Washington Post
Acadia Pharmaceuticals to Present at Canaccord Genuity 45th Annual Growth Conference - AInvest
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference - Lelezard
Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer - Business Wire
ACADIA Pharmaceuticals Inc. At Decision Level — Rebound or ResistanceReal Profit Trade Plan Suggestions Shared Widely - metal.it
Does ACADIA Pharmaceuticals Inc. stock perform well during market downturnsDiscover high-growth stocks for your portfolio - Jammu Links News
What is the dividend policy of ACADIA Pharmaceuticals Inc. stockTurn volatility into profit opportunities - Jammu Links News
How many analysts rate ACADIA Pharmaceuticals Inc. as a “Buy”Grow your portfolio with growth-oriented stocks - Jammu Links News
How volatile is ACADIA Pharmaceuticals Inc. stock compared to the marketCapitalize on momentum stocks early - Jammu Links News
Is ACADIA Pharmaceuticals Inc. a growth stock or a value stockAchieve rapid returns with smart investment plans - Jammu Links News
What are the technical indicators suggesting about ACADIA Pharmaceuticals Inc.Free Predictions - Jammu Links News
How strong is ACADIA Pharmaceuticals Inc. company’s balance sheetAchieve rapid portfolio appreciation today - Jammu Links News
0.40%
2.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):